A Study of RSLV-132 in Females With Sjögren's Syndrome

Recruiting

Phase 2

RSLV-132A Study of RSLV-132 in Females With Sjögren's Syndrome

Sponsor:

Resolve Therapeutics

Code:

NCT06440525

Conditions

Primary Sjögren Syndrome

Eligibility Criteria

Sex: Female

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

RSLV-132

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-22. This information was provided to ClinicalTrials.gov by Resolve Therapeutics on 2025-04-24.